The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients-Reference-Cited by-同舟云学术

The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients

Published:2012-01-06 Issue:6 Volume:14 Page:518-522
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Fadini G. P.,Albiero M.,Menegazzo L.,de Kreutzenberg S. V.,Avogaro A.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01550.x/fullpdf

Reference21 articles.

1. Pharmacological management of type 2 diabetes: the potential of incretin-based therapies.;Charbonnel;Diabetes Obes Metab,2011

2. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.;Meier;Diabetologia,2006

3. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.;Ryskjaer;Eur J Endocrinol,2006

4. Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes.;Han;Diabetes Res Clin Pract,2010

5. Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.;Firneisz;PLoS One,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 70 years of metformin use. Success and achievements;FOCUS. Endocrinology;2024-05-13

2. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

3. Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes;Frontiers in Endocrinology;2024-02-27

4. Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology;Current Medicinal Chemistry;2024-02-21

5. Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients;Biomarkers in Medicine;2022-04